Predictors of in-hospital mortality and length of stay in community-acquired pneumonia: a 5-year multi-centre case control study of adults in a developing country

Trans R Soc Trop Med Hyg. 2016 Aug;110(8):445-55. doi: 10.1093/trstmh/trw057. Epub 2016 Sep 12.

Abstract

Background: We investigated predictors of in-hospital mortality and length of hospital stay among adults with community-acquired pneumonia (CAP) in Nigeria in order to provide recommendations to improve CAP outcomes in developing countries.

Methods: This was a multi-centre case control study of patients ≥18 years who were admitted with CAP between 2008 and 2012. Case notes of 100 consecutive patients who died (cases) and random sample of 300 patients discharged (controls) were selected.

Results: Mean ages were 55.4±19.6 (cases) and 49.3±19.2 (controls). Independent predictors of mortality were CURB-65 score ≥3: adjusted odds ratio (aOR) 24.3, late presentation: aOR 8.6, co-morbidity: aOR 3.9, delayed first dose antibiotics (>4 hours): aOR 3.5, need for supplemental oxygen: aOR 4.9, multilobar pneumonia: aOR 4.0, non-pneumococcal aetiology: aOR 6.5, anaemia: aOR 3.8 and hyperglycemia: aOR 8.6. CURB-65 ≥3 predicted mortality with a high specificity (96.1%) but low sensitivity (75%); positive predictive value of 88.2% and negative predictive value of 90.8%. Care in hospital A and B: aOR 3.3 and 2.2 respectively, male gender aOR 2.1, co-morbidity aOR 3.0, anaemia aOR 2.1 and elevated serum creatinine aOR 6.3 independently predicted length of hospital stay >10 days among survivors.

Conclusions: Several modifiable patient-related and process-of-care factors predicted in-hospital mortality, and length of hospital stay among survivors. Our findings should be used to improve CAP outcomes in developing countries.

Keywords: Community-acquired pneumonia; Developing countries; Length of hospital stay; Mortality; Nigeria; Predictors.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anemia / complications
  • Anti-Bacterial Agents / therapeutic use
  • Case-Control Studies
  • Community-Acquired Infections / complications
  • Community-Acquired Infections / microbiology
  • Community-Acquired Infections / mortality
  • Community-Acquired Infections / therapy*
  • Comorbidity
  • Creatinine / blood
  • Delivery of Health Care*
  • Developing Countries*
  • Female
  • Hospital Mortality*
  • Hospitals*
  • Humans
  • Hyperglycemia / complications
  • Length of Stay*
  • Male
  • Middle Aged
  • Nigeria
  • Oxygen / blood
  • Pneumonia / complications
  • Pneumonia / microbiology
  • Pneumonia / mortality
  • Pneumonia / therapy*
  • Risk Factors
  • Streptococcus pneumoniae

Substances

  • Anti-Bacterial Agents
  • Creatinine
  • Oxygen